Diagnostic potential of endosonography in primary and secondary esophageal tumors: retrospective study
- 作者: Khalaev Z.1, Suleymanov E.2, Malikhova O.3,4, Tumanyan A.3, Krylovetskaia M.3, Kontsevaya A.3, Salimova A.3, Makarova M.3
-
隶属关系:
- Medical Company, AiMed Family Clinic
- National Medical Radiology Research Center
- Blokhin National Medical Research Center of Oncology
- Russian Medical Academy of Continuous Professional Education
- 期: 卷 24, 编号 3 (2022)
- 页面: 384-388
- 栏目: CLINICAL ONCOLOGY
- URL: https://journals.rcsi.science/1815-1434/article/view/109975
- DOI: https://doi.org/10.26442/18151434.2022.3.201884
- ID: 109975
如何引用文章
全文:
详细
Aim. To determine the diagnostic value of endosonography in primary and secondary esophageal tumors.
Materials and methods. Between 2018 and 2022, 118 patients with primary and secondary esophageal changes were managed at the Blokhin National Medical Research Center for Oncology. Primary changes imply invasion of the esophagus directly by a tumor, secondary changes mean invasion of the esophageal wall by a tumor from outside, and the transition of a tumor from the stomach to the esophagus.
Results. All patients had esophagogastroduodenoscopy combined with endoscopic ultrasound performed. Besides estimating the tumor invasion depth in the esophageal wall and the possible involvement of other structures at a distance up to 5 cm from the esophagus, the proximal margin of the tumor was examined. According to esophagogastroduodenoscopy and endoscopic ultrasound examination, the difference in the proximal margin was not more than 1.0 cm. The difference in results may be due to the submucosal nature of tumor growth.
Conclusion. Endoscopic ultrasound examination is the most important diagnostic method to determine the proximal margin of the primary and secondary esophageal tumors and evaluate the degree of invasion into the esophageal wall, which is an essential factor for the treatment choice.
作者简介
Zalimkhan Khalaev
Medical Company, AiMed Family Clinic
Email: mariyakrilo@gmail.com
ORCID iD: 0000-0003-0688-2879
Department Head
俄罗斯联邦, GroznyElkhan Suleymanov
National Medical Radiology Research Center
Email: mariyakrilo@gmail.com
ORCID iD: 0000-0002-5140-0245
D. Sci. (Med.), Prof. RAS
俄罗斯联邦, MoscowOlga Malikhova
Blokhin National Medical Research Center of Oncology; Russian Medical Academy of Continuous Professional Education
Email: mariyakrilo@gmail.com
ORCID iD: 0000-0003-0829-7809
D. Sci. (Med.), Prof.
俄罗斯联邦, Moscow; MoscowArmen Tumanyan
Blokhin National Medical Research Center of Oncology
Email: mariyakrilo@gmail.com
ORCID iD: 0000-0001-5863-5197
D. Sci. (Med.)
俄罗斯联邦, MoscowMariia Krylovetskaia
Blokhin National Medical Research Center of Oncology
编辑信件的主要联系方式.
Email: mariyakrilo@gmail.com
ORCID iD: 0000-0002-0868-3948
Endoscopist
俄罗斯联邦, MoscowAnna Kontsevaya
Blokhin National Medical Research Center of Oncology
Email: mariyakrilo@gmail.com
ORCID iD: 0000-0001-5816-9106
Cand. Sci. (Med.)
俄罗斯联邦, MoscowAlina Salimova
Blokhin National Medical Research Center of Oncology
Email: mariyakrilo@gmail.com
ORCID iD: 0000-0002-5614-8405
Endoscopist
俄罗斯联邦, MoscowMariia Makarova
Blokhin National Medical Research Center of Oncology
Email: mariyakrilo@gmail.com
ORCID iD: 0000-0002-5277-7757
Resident
俄罗斯联邦, Moscow参考
- Давыдов М.И., Стилиди И.С. Рак пищевода. М.: Издательская группа РОНЦ. Практическая медицина, 2007 [Davydov MI, Stilidi IS. Rak pishchevoda. Moscow: Izdatel'skaia gruppa RONTs. Prakticheskaia meditsina, 2007 (in Russian)].
- Руководство по химиотерапии опухолевых заболеваний. Под ред. Н.И. Переводчиковой, В.А. Горбуновой. М., 2015 [Rukovodstvo po khimioterapii opukholevykh zabolevanii. Pod red. NI Perevodchikovoi, VA Gorbunovoi. Moscow, 2015 (in Russian)].
- Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. О.В. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2022 [Zlokachestvennye novoobrazovaniia v Rossii v 2021 godu (zabolevaemost' i smertnost'). Pod red. OV Kaprina, VV Starinskogo, GV Petrovoi. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTs” Minzdrava Rossii, 2022 (in Russian)].
- Choi J, Kim SG, Kim JS, et al. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET) and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc. 2010;24:1380-6. doi: 10.1007/s00464-009-0783-x
- Ishihara R, Goda K, Oyama T. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus. J Gastroenterol. 2019;54(1):1-9. doi: 10.1007/s00535-018-1491-x
- May A, Günter E, Roth F, et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut. 2004;53(5):634-40. doi: 10.1136/gut.2003.029421
- Иванов С.М. Химиолучевая терапия рака пищевода. Практическая онкология. 2008;9(1):21-6 [Ivanov SM. Khimioluchevaia terapiia raka pishchevoda. Prakticheskaia onkologiia. 2008;9(1):21-6 (in Russian)].
- Канаев С.В., Щербаков А.М., Тюряева Е.И. Консервативное лечение местнораспространенного и неоперабельного рака пищевода: возможности и перспективы. Вопросы онкологии. 2012;58(2):199-202 [Kanaev SV, Shcherbakov AM, Tiuriaeva EI. Konservativnoe lechenie mestnorasprostranennogo i neoperabel'nogo raka pishchevoda: vozmozhnosti i perspektivy. Voprosy onkologii. 2012;58(2):199-202 (in Russian)].